Therefore, the presence of anti-ENO autoantibodies and T cells prompted us to verify the hypothesis of eliciting a strong anti-ENO1 immune response by a DNA vaccine, able to counteract tumor progression. This evidence concerns the gene ENO1 and neoplasm.